These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

899 related articles for article (PubMed ID: 27025401)

  • 1. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction.
    Zhao L; Liu X; Zhang Y; Liang X; Ding Y; Xu Y; Fang Z; Zhang F
    Exp Cell Res; 2016 May; 344(1):30-39. PubMed ID: 27025401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
    Deuse T; Peter C; Fedak PW; Doyle T; Reichenspurner H; Zimmermann WH; Eschenhagen T; Stein W; Wu JC; Robbins RC; Schrepfer S
    Circulation; 2009 Sep; 120(11 Suppl):S247-54. PubMed ID: 19752375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of NUCKS augments paracrine effects of mesenchymal stem cells-mediated cardiac protection.
    Zhang Y; Chiu S; Liang X; Chai YH; Qin Y; Wang J; Li X; Qiu B; Tergaonkar V; Tse HF; Lian Q
    Exp Cell Res; 2017 Jul; 356(1):74-84. PubMed ID: 28412246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxic adipose mesenchymal stem cells derived conditioned medium protects myocardial infarct in rat.
    He J; Cai Y; Luo LM; Liu HB
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4397-406. PubMed ID: 26636529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
    Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
    Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.
    Hung SC; Pochampally RR; Chen SC; Hsu SC; Prockop DJ
    Stem Cells; 2007 Sep; 25(9):2363-70. PubMed ID: 17540857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.
    Liu CB; Huang H; Sun P; Ma SZ; Liu AH; Xue J; Fu JH; Liang YQ; Liu B; Wu DY; Lü SH; Zhang XZ
    Stem Cells Transl Med; 2016 Aug; 5(8):1004-13. PubMed ID: 27334487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemin pre-treatment augments the cardiac protection of mesenchymal stem cells by inhibiting mitochondrial fission and improving survival.
    Deng R; Liu Y; He H; Zhang H; Zhao C; Cui Z; Hong Y; Li X; Lin F; Yuan D; Liang X; Zhang Y
    J Cell Mol Med; 2020 Jan; 24(1):431-440. PubMed ID: 31660694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
    Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
    FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
    Wang S; Qin X; Sun D; Wang Y; Xie X; Fan W; Wang Y; Liang D; Pei X; Cao F
    Cell Biochem Funct; 2012 Oct; 30(7):574-81. PubMed ID: 22592978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis.
    Shen C; Lie P; Miao T; Yu M; Lu Q; Feng T; Li J; Zu T; Liu X; Li H
    Mol Med Rep; 2015 Jul; 12(1):20-30. PubMed ID: 25739039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction.
    Tang J; Wang J; Guo L; Kong X; Yang J; Zheng F; Zhang L; Huang Y
    Mol Cells; 2010 Jan; 29(1):9-19. PubMed ID: 20016947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.
    Shen H; Cui G; Li Y; Ye W; Sun Y; Zhang Z; Li J; Xu G; Zeng X; Zhang Y; Zhang W; Huang Z; Chen W; Shen Z
    Stem Cell Res Ther; 2019 Jan; 10(1):17. PubMed ID: 30635025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy.
    Zhang Y; Liang X; Liao S; Wang W; Wang J; Li X; Ding Y; Liang Y; Gao F; Yang M; Fu Q; Xu A; Chai YH; He J; Tse HF; Lian Q
    Sci Rep; 2015 Jun; 5():11235. PubMed ID: 26057572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis.
    Cahill EF; Kennelly H; Carty F; Mahon BP; English K
    Stem Cells Transl Med; 2016 Oct; 5(10):1307-1318. PubMed ID: 27388243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.
    Hu X; Yu SP; Fraser JL; Lu Z; Ogle ME; Wang JA; Wei L
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):799-808. PubMed ID: 18374759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine effect of CXCR4-overexpressing mesenchymal stem cells on ischemic heart injury.
    Wu SZ; Li YL; Huang W; Cai WF; Liang J; Paul C; Jiang L; Wu ZC; Xu M; Zhu P; Wang Y
    Cell Biochem Funct; 2017 Mar; 35(2):113-123. PubMed ID: 28233339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement.
    Gnecchi M; He H; Noiseux N; Liang OD; Zhang L; Morello F; Mu H; Melo LG; Pratt RE; Ingwall JS; Dzau VJ
    FASEB J; 2006 Apr; 20(6):661-9. PubMed ID: 16581974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.